Raymond Sw Tsang1, Michelle Shuel1, Kristy Hayden1, Paul Van Caeseele2, Derek Stein2,3. 1. Syphilis Diagnostic Unit, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB. 2. Cadham Provincial Public Health Laboratory, Winnipeg, MB. 3. Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB.
Abstract
Background: Syphilis is a sexually transmitted disease that can have atypical clinical presentations. Conventional laboratory tests to confirm the diagnosis are not rapid enough to affect clinical decision on treatment and contact tracing. Rapid point-of-care tests (POCT) can be useful for control of infectious diseases; however, no POCT for syphilis detection is currently available in Canada. The aim of this study is to evaluate two POCTs (RevealTM Rapid TP (Treponema pallidum) Antibody test and DPP® Syphilis Screen and Confirm test) for detection of infectious syphilis. Methods: One hundred serum samples with known syphilis serological status, based on treponemal and non-treponemal test results, were analysed in the laboratory with two POCTs by two independent operators in a blind fashion. Results were analysed to evaluate their ability to detect infectious syphilis. Results: The Reveal Rapid TP Antibody POCT showed an overall sensitivity of 95.0% and a specificity of 83.3%, while the DPP Syphilis Screen and Confirm POCT showed a sensitivity of 87.5% and a specificity of 98.3%. Both POCTs gave a sensitivity of 100% on active syphilis samples with Venereal Disease Research Laboratory (VDRL) titres of greater than 1:4, but their sensitivities decreased for samples with low VDRL titres. Both POCTs gave weakly or very weakly reactive results on 11.3%-25.0% of the treponemal antibody positive samples. Conclusion: This laboratory evaluation has shown promising results for both POCTs to detect infectious syphilis. Further evaluations in the field would be required to confirm this preliminary finding.
Background: Syphilis is a sexually transmitted disease that can have atypical clinical presentations. Conventional laboratory tests to confirm the diagnosis are not rapid enough to affect clinical decision on treatment and contact tracing. Rapid point-of-care tests (POCT) can be useful for control of infectious diseases; however, no POCT for syphilis detection is currently available in Canada. The aim of this study is to evaluate two POCTs (RevealTM Rapid TP (Treponema pallidum) Antibody test and DPP® Syphilis Screen and Confirm test) for detection of infectious syphilis. Methods: One hundred serum samples with known syphilis serological status, based on treponemal and non-treponemal test results, were analysed in the laboratory with two POCTs by two independent operators in a blind fashion. Results were analysed to evaluate their ability to detect infectious syphilis. Results: The Reveal Rapid TP Antibody POCT showed an overall sensitivity of 95.0% and a specificity of 83.3%, while the DPP Syphilis Screen and Confirm POCT showed a sensitivity of 87.5% and a specificity of 98.3%. Both POCTs gave a sensitivity of 100% on active syphilis samples with Venereal Disease Research Laboratory (VDRL) titres of greater than 1:4, but their sensitivities decreased for samples with low VDRL titres. Both POCTs gave weakly or very weakly reactive results on 11.3%-25.0% of the treponemal antibody positive samples. Conclusion: This laboratory evaluation has shown promising results for both POCTs to detect infectious syphilis. Further evaluations in the field would be required to confirm this preliminary finding.
Authors: S R Leon; L B Ramos; S K Vargas; N Kojima; D G Perez; C F Caceres; J D Klausner Journal: J Clin Microbiol Date: 2015-12-09 Impact factor: 5.948
Authors: Antonella Zorzi; Maddalena Cordioli; Lorenzo Gios; Paola Del Bravo; Igor Toskin; Rosanna W Peeling; Karel Blondeel; Giuseppe Cornaglia; James Kiarie; Ronald Ballard; Massimo Mirandola Journal: Sex Transm Infect Date: 2017-12 Impact factor: 3.519
Authors: Harriet D Gliddon; Rosanna W Peeling; Mary L Kamb; Igor Toskin; Teodora E Wi; Melanie M Taylor Journal: Sex Transm Infect Date: 2017-07-26 Impact factor: 3.519
Authors: Karilany Dantas Coutinho; Ricardo A de M Valentim; Geir Veras Vieira; Maíra Sidrim; Pedro Henrique Germano Evangelista; Laís Pereira de Oliveira Journal: Front Public Health Date: 2022-04-29
Authors: Chelsea Caya; Mathieu Maheu-Giroux; Yiqing Xia; Bouchra Serhir; Veronique Morin; Michael Libman; Rachel Corsini; David M Goldfarb; Tom Wong; Ameeta E Singh; Cedric P Yansouni Journal: PLoS One Date: 2022-09-12 Impact factor: 3.752